全文获取类型
收费全文 | 48824篇 |
免费 | 4730篇 |
国内免费 | 3349篇 |
专业分类
耳鼻咽喉 | 512篇 |
儿科学 | 630篇 |
妇产科学 | 591篇 |
基础医学 | 5752篇 |
口腔科学 | 924篇 |
临床医学 | 6412篇 |
内科学 | 7091篇 |
皮肤病学 | 585篇 |
神经病学 | 2510篇 |
特种医学 | 1742篇 |
外国民族医学 | 19篇 |
外科学 | 4747篇 |
综合类 | 8365篇 |
现状与发展 | 11篇 |
一般理论 | 12篇 |
预防医学 | 3634篇 |
眼科学 | 1365篇 |
药学 | 5042篇 |
42篇 | |
中国医学 | 3018篇 |
肿瘤学 | 3899篇 |
出版年
2024年 | 132篇 |
2023年 | 697篇 |
2022年 | 1744篇 |
2021年 | 2495篇 |
2020年 | 1908篇 |
2019年 | 1615篇 |
2018年 | 1727篇 |
2017年 | 1636篇 |
2016年 | 1514篇 |
2015年 | 2122篇 |
2014年 | 2639篇 |
2013年 | 2592篇 |
2012年 | 3744篇 |
2011年 | 3963篇 |
2010年 | 2587篇 |
2009年 | 2149篇 |
2008年 | 2800篇 |
2007年 | 2721篇 |
2006年 | 2591篇 |
2005年 | 2419篇 |
2004年 | 1776篇 |
2003年 | 1710篇 |
2002年 | 1478篇 |
2001年 | 1160篇 |
2000年 | 1102篇 |
1999年 | 1009篇 |
1998年 | 652篇 |
1997年 | 573篇 |
1996年 | 438篇 |
1995年 | 472篇 |
1994年 | 389篇 |
1993年 | 256篇 |
1992年 | 330篇 |
1991年 | 297篇 |
1990年 | 220篇 |
1989年 | 210篇 |
1988年 | 207篇 |
1987年 | 163篇 |
1986年 | 131篇 |
1985年 | 105篇 |
1984年 | 64篇 |
1983年 | 66篇 |
1982年 | 24篇 |
1981年 | 32篇 |
1980年 | 30篇 |
1979年 | 46篇 |
1978年 | 16篇 |
1977年 | 24篇 |
1976年 | 16篇 |
1973年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 257 毫秒
51.
A. Roosaar L. Yin G. Sandborgh-Englund O. Nyrén T. Axéll 《Journal of oral pathology & medicine》2006,35(5):257-261
OBJECTIVES: The aim was to assess the natural course of oral lichen lesions (OLL) among unselected, non-consulting individuals. SUBJECTS AND METHODS: A cohort of 327 subjects with OLL, confirmed in 1973-1974 during a population-based survey in two Swedish municipalities, was followed through January 2002 via record linkages with nationwide and essentially complete registers. A sample of 80 drawn from the 194 surviving subjects who still resided in the area in 1993-1995 was invited for interview and oral re-examination. RESULTS: At the end of follow-up, one case of oral cancer was detected, while 0.4 were expected. The overall mortality among subjects with OLL was not significantly different from that in the 15,817 OLL-free subjects who participated in the initial population based survey in 1973-1974. The lesion had disappeared in 14 (39%) of 36 re-examined subjects with white OLLs in 1973-1974, and four (11%) had transformed into red types. In the corresponding group of 19 with red forms initially, five (26%) had become lesion free and four (21%) had switched to white types. Although the cohort size does not permit firm conclusions regarding oral cancer risk, the natural course over up to 30 years appears to be benign in the great majority. 相似文献
52.
Phoebe S. Y. Lo Michael C. F. Tong Dennis A. Revicki Ching Chyi Lee John K. S. Woo Henry C. K. Lam C. Andrew van Hasselt 《Quality of life research》2006,15(5):877-887
Background: The Rhinitis Symptom Utility Index (RSUI), originally developed in the United States, consists of a patient-preference weighting
scheme and a 10-item questionnaire measuring the severity and frequency of rhinitis related symptoms over a 14-day period.
This study aimed to determine whether the Chinese RSUI could adopt the US-based multi-attribute utility function (MAUF) in
scoring rhinitis symptoms. Methods: In a Hong Kong study, 116 Chinese adults with allergic rhinitis completed the RSUI questionnaire and 36-item Short-Form
Health Survey (SF-36) after they had been seen by two otorhinolaryngologists for disease-severity ratings. Respondents then
completed computer-administered direct preference measures, i.e., visual analogue scale (VAS) and standard gamble (SG) assessments.
The VAS and SG data were used to estimate a MAUF for the Chinese-based RSUI. Results: The derived MAUF was somewhat different than the one developed for the US RSUI. Test–retest reliability for the Chinese
RSUI was satisfactory (ICC = 0.71, p<0.001). Scores differentiated among cases with mild, moderate, and severe symptoms (p<0.001); and between those who did and did not require medications to control symptoms (p = 0.031). Findings were significantly correlated with SF-36 domain scores (r = 0.19 to 0.37; p=0.041 to <0.001). When the US-based scoring function was applied to the Chinese subjects, the resulting mean RSUI score was
significantly lower (p<0.001). Comparisons between directly measured VAS and SG scores between the US and Chinese samples, demonstrated significant
differences (all p<0.05), with the US subjects consistently rating rhinitis symptoms as worse than Chinese subjects. Conclusions: The Chinese RSUI has good measurement properties that reflect patient preferences from the Chinese. Results suggest that
there are differences in preference rating between US and Chinese subjects and that use of the US-based preference function
for the RSUI would bias the measurement of rhinitis symptom outcomes in Chinese subjects. 相似文献
53.
Bill J Gurley Ashley Swain Gary W Barone D Keith Williams Philip Breen C Ryan Yates Leslie B Stuart Martha A Hubbard Yudong Tong Sreekhar Cheboyina 《Drug metabolism and disposition》2007,35(2):240-245
Phytochemical-mediated modulation of P-glycoprotein (P-gp) and other drug transporters may give rise to many herb-drug interactions. Serial plasma concentration-time profiles of the P-gp substrate, digoxin, were used to determine whether supplementation with goldenseal or kava kava modified P-gp activity in vivo. Twenty healthy volunteers were randomly assigned to receive a standardized goldenseal (3210 mg daily) or kava kava (1227 mg daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (600 mg daily, 7 days) and clarithromycin (1000 mg daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin, 0.5 mg) was administered p.o. before and at the end of each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), C(max,) CL/F, and elimination half-life were used to assess the effects of goldenseal, kava kava, rifampin, and clarithromycin on digoxin pharmacokinetics. Rifampin produced significant reductions (p < 0.01) in AUC((0-3)), AUC((0-24)), CL/F, t(1/2), and C(max), whereas clarithromycin increased these parameters significantly (p < 0.01). With the exception of goldenseal's effect on C(max) (14% increase), no statistically significant effects on digoxin pharmacokinetics were observed following supplementation with either goldenseal or kava kava. When compared with rifampin and clarithromycin, supplementation with these specific formulations of goldenseal or kava kava did not appear to affect digoxin pharmacokinetics, suggesting that these supplements are not potent modulators of P-gp in vivo. 相似文献
54.
以曼氏血吸虫的虫卵和成虫免疫家兔后所产生的特异性抗体,可用以日本血吸虫虫卵、尾蚴和成虫为抗原分别进行的COP,CHR和ELACIEP测出,表明两种人体血吸虫存有显著的交叉抗原成分。应用此种血清交叉反应性,以检测抗异种人体血吸虫的抗体,似有效而可取的,可用以辅助诊断援外回国人员是否感染国外人体血吸虫病。 相似文献
55.
56.
目的研究高原地区,脱髓鞘疾病与中老年人疾病等因素的关系。方法对我院所有接受过磁共振头部扫描的病人进行评估,确诊出40位脱髓鞘疾病患者,并对大脑7个部位的脱髓鞘疾病按严重性分4级打分,统计临床数据,最后运用统计学方法分析其相关性。结果在40例患者中,出现在大脑半球、放射冠、半卵圆中心和脑室前后角的脑白质损伤频率最多,分别占总量的50%、67.5%、77.5%和87.5%。脑白质损伤患者的平均年龄为47.1岁,这比世界其他地区都有明显的提前。男性患者将近是女性患者的3倍(29∶11)。年龄、慢性高原红细胞增多症、收缩压、脑梗塞与脑白质损伤正相关(P<0.05)。结论对于高海拔地区,有效控制高原心血管疾病的发生对于减少颅脑脱髓鞘疾病的发生具有重要意义。 相似文献
57.
便秘是老年糖尿病患者的常见合并症之一.笔者自2006年6月~2007年6月以济川煎为基础方加味治疗老年糖尿病患者合并便秘24例,现报道如下.
…… 相似文献
58.
兔骨髓间充质干细胞Ⅱ型胶原表达的实验研究 总被引:1,自引:1,他引:0
目的探讨兔骨髓间充质干细胞表达Ⅱ型胶原的实验研究方法。方法利用β1转化生长因子腺病毒表达载体(Ad—TGFβ1)转染兔骨髓间充质干细胞(MSCs),观察转染后的Ⅱ型胶原表达。结果细胞转染后Ⅱ型胶原在免疫印记和免疫组化检测下均呈强阳性表达。结论Ad—TGFβI转染兔骨髓MSCs可使其细胞内Ⅱ型胶原表达阳性。 相似文献
59.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
60.